Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial.
Mei H, Liu X, Li Y, Zhou H, Feng Y, Gao G, Cheng P, Huang R, Yang L, Hu J, Hou M, Yao Y, Liu L, Wang Y, Wu D, Shen X, Jin J, Luo J, Zeng Y, Zhou X, Xia R, Jiang Z, Bai Y, Niu T, Yang R, Hu Y.
Mei H, et al. Among authors: liu x, liu l.
Ann Hematol. 2024 Jul;103(7):2273-2281. doi: 10.1007/s00277-024-05826-5. Epub 2024 Jun 6.
Ann Hematol. 2024.
PMID: 38842566
Free PMC article.
Clinical Trial.